Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net loss	$ (6,258,596)	$ (4,160,196)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization	98,075	54,840
Accretion of debt discount	2,007,687	0
Loss on disposal of property and equipment	0	12,978
Stock Based Compensation	113,171	565,039
Changes in assets and liabilities:
Prepaid expenses	(767,050)	186,281
Increase in inventory	(564,313)	(258,523)
Accounts payable	(39,914)	138,485
Liability due to related party	(681,298)	(91,347)
Other liabilities and accrued expenses	94,141	102,898
Net cash used in operating activities	(5,998,097)	(3,449,545)
Cash Flows from Investing Activities:
Capitalized patent costs	(81,952)	(53,206)
Purchase of property and equipment	(90,730)	(157,825)
Capitalized software development costs	(663,758)	0
Net cash used in investing activities	(836,440)	(211,031)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock	15,750,672	152,492
Costs incurred in relation to equity financing	(957,193)	(40,365)
Proceeds from warrant exercise	400,503	26,000
Proceeds from issuance of notes payable	25,000,000	0
Debt issuance costs paid	(1,525,035)	0
Repayments of notes payable	(600,000)	0
Repayments of insurance financing	(82,555)	(40,896)
Net cash provided by financing activities	37,986,392	97,231
Net increase/(decrease)/ in cash	31,151,855	(3,563,345)
Effect of exchange rate changes on cash	607,409	(71,212)
Cash at beginning of year	106,107	3,740,664
Cash at end of year	31,865,371	106,107
Supplemental disclosure of non-cash financing activities:
Prepayment of equity compensation	50,000	27,400
Amount of insurance funded through note payable	0	123,491
Licenses acquired through stock issuance	100,000	0
Monitoring fees added to notes payable	$ 718,661	$ 0